Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Geriatr Soc. 2009 Mar;57(3):403-11. doi: 10.1111/j.1532-5415.2008.02130.x.

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.

Author information

  • 1Department of Surgery, St Michaels Hospital, Toronto, Canada. baxtern@smh.toronto.on.ca

Abstract

OBJECTIVES:

To assess whether there is an association between delivery of adjuvant chemotherapy to older women with breast cancer and development of dementia over time.

DESIGN:

Retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) data linked to Medicare claims data.

SETTING:

Women residing in geographic areas included in the SEER registry.

PARTICIPANTS:

Women aged 66 to 80 diagnosed with non-metastatic invasive breast cancer from 1992 to 1999 were included. It was determined whether patients had undergone chemotherapy within 6 months of diagnosis.

MEASUREMENTS:

Whether women developed dementia over time was determined using diagnostic codes. The effect of adjuvant chemotherapy on development of dementia was evaluated, adjusting for confounders using a proportional hazards model stratified for age.

RESULTS:

Twenty-one thousand three hundred sixty-two women met selection criteria; 2,913 received chemotherapy, and 18,449 did not. Women who received chemotherapy were younger than those who did not (median aged 70 vs 73; P<.001). Median follow-up time was 59 months. After controlling for other factors, it was found that chemotherapy was not associated with a greater risk of development of dementia over time for any age group (hazard ratio for dementia in women receiving chemotherapy: aged 66-70=0.83, 95% confidence interval (CI)=0.48-1.45, P=.5; aged 71-75=0.74, 95% CI=0.46-1.18, P=.2; aged 76-80=0.49, 95% CI=0.28-0.88, P=.02).

CONCLUSION:

Receipt of chemotherapy in older women with breast cancer was not associated with a greater risk of dementia diagnosis over time; very elderly women who undergo chemotherapy may be at lower baseline risk. The use of a claims-based definition of dementia limited the study.

PMID:
19278395
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk